An inter-disciplinary team led by Prof. Peiyuan QIAN unearthed the missing link using a novel biosynthetic method of colibactin, released by Escherichia coli (E. coli) and unraveled how it is connected to colorectal cancer, offering new insights to the health impact of this prevalent bacteria and facilitating future research on the prevention of this third most common cancer worldwide.

The team not only succeeded in cloning the colibactin gene cluster, but also found a way to mass produce the genes for testing and validation. After repeated assays of various sets of colibactin precursors, the team eventually identified colibactin-645 as the culprit of the DNA double-strand breaks, and uncovered colibactin metabolite's biosynthetic pathway as well as its mechanism of causing DNA damage. The findings have been published in the prestigious scientific journal Nature Chemistry and the early findings on colibactin were published in another scientific journal Nature Chemical Biology.